Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.38 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | RAC2 | P15153 | 1/20 | 0.32 |
| ▸ | RAC3 | P60763 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 1/20 | 0.32 |
| ▸ | RAC1 | P63000 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14521275 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL29373704 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL14521305 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL29363227 | 0.99 | KDM4E (0.49) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL14521278 | 0.99 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL261368 | 0.99 | KDM4E (0.49) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL14362620 | 0.99 | L3MBTL1 (0.49) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL8406163 | 0.97 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL14362587 | 0.97 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2ATSPO | |
| SCHEMBL14521285 | 0.97 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMKMT2ATSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638938-B1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND ASSOCIATED DISEASES | SIGA TECH INC (US) | 2017-04-12 | — | — | EP | claimed |
| US-8124643-B2 | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2012-02-28 | — | — | US | claimed |
| US-8039504-B2 | heating a mixture of anti-tricyclo[3.2.2.0]non-6-ene-endo-8, endo-9-dicarboxylic acid anhydride, 4-(trifluoromethyl)benzhydrazide, and ethanol at reflux, concetrating and recrystallizing; 4-Trifluoromethyl-N- (3,3a,4,4a,5,5a,6,6a,- octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol- 2(1H)-yl)-benzamide | SIGA TECHNOLOGIES, INC. (US) | 2011-10-18 | — | — | US | claimed |
| US-7737168-B2 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2010-06-15 | — | — | US | claimed |
| US-20080103181-A9 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2008-05-01 | — | — | US | claimed |
| US-20060235051-A1 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2006-10-19 | — | — | US | claimed |
| US-20260148713-A1 | DISPLAY DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-20260146024-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-20260140538-A1 | DISPLAY APPARATUS AND OPERATION METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO LTD (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260143939-A1 | Light-Emitting Device And Display Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260132134-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, THIN FILM, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO LTD (JP) | 2026-05-14 | — | — | US | disclosed |
| US-20260130046-A1 | ORGANIC COMPOUND, ORGANIC SEMICONDUCTOR DEVICE, AND LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2026-05-07 | — | — | US | disclosed |
| US-12622147-B2 | Display device, display module, electronic device, and television device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20070287735-A1 | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20070075632-A1 | Anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| WO-2007029530-A1 | ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007029530-A1 | ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-03-15 | — | — | WO | disclosed |
| US-20060235051-A1 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | SIGA TECHNOLOGIES, INC. (US) | 2006-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260140538-A1 | DISPLAY APPARATUS AND OPERATION METHOD THEREOF | VSIG8, STRA6, HAVCR2 | L3MBTL1 1403/4885KDM4E 2778/4885ATM 3816/4885 |
| US-20260143939-A1 | Light-Emitting Device And Display Device | L1CAM, STRA6, IK | L3MBTL1 357/4885KDM4E 2641/4885ATM 2282/4885 |
| US-20260132134-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, THIN FILM, LIGHT-EMITTING APPARATUS, ELECTRONIC APPARATUS, AND LIGHTING DEVICE | CRY1, CTNNA1, CRY2 | L3MBTL1 422/4885KDM4E 2840/4885ATM 1921/4885 |
| US-20070287735-A1 | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | OTC, FAHD1, OAT | L3MBTL1 1899/4885KDM4E 3057/4885ATM 3030/4885 |
| US-20060235051-A1 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | OTC, FAHD1, OAT | L3MBTL1 1630/4885KDM4E 3219/4885ATM 3112/4885 |
| US-12622147-B2 | Display device, display module, electronic device, and television device | NECTIN4, HTR3D, CHRNA4 | L3MBTL1 2326/4885KDM4E 3085/4885ATM 4447/4885 |
| US-20070075632-A1 | Anthracene derivative | CRY2, XPOT, CRY1 | L3MBTL1 2830/4885KDM4E 3133/4885ATM 198/4885 |
| US-20260146024-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Apparatus, and Lighting Device | NR2E3, CCNE2, CCND3 | L3MBTL1 473/4885KDM4E 3317/4885ATM 944/4885 |
| US-20080103181-A9 | Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases | OTC, FAHD1, OAT | L3MBTL1 1630/4885KDM4E 3219/4885ATM 3112/4885 |
| US-20260148713-A1 | DISPLAY DEVICE | NOTCH4, DNER, NOTCH2 | L3MBTL1 3125/4885KDM4E 1245/4885ATM 550/4885 |
| US-20260130046-A1 | ORGANIC COMPOUND, ORGANIC SEMICONDUCTOR DEVICE, AND LIGHT-EMITTING DEVICE | SCO2, RPS8, RPS19 | L3MBTL1 360/4885KDM4E 4412/4885ATM 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.